Spiracur raises $16m from GE Capital

Spiracur says it raised a $16 million debt round from GE Capital for its SNaP negative-pressure wound therapy device.

Spiracur said today that it raised $16 million debt round from GE Capital for its negative-pressure wound therapy device.

Sunnyvale, Calif.-based Spiracur said it plans to use the proceeds to launch new products, penetrate new care settings and for global expansion.

GE Capital, Spiracur

News Well, Funding Roundup, Negative-Pressure Wound Therapy

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sEwnA0